Search Results

You are looking at 1 - 1 of 1 items for

  • Author or Editor: Andrea Heinzlmann x
Clear All Modify Search

Introduction

It was previously shown that intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) prior to GnRH mobilization in proestrus prevents ovulation in rats. In this study, we examined whether PACAP given intranasally could influence luteinizing hormone (LH) and prolactin (PRL) surges and ovulation.

Methods

On the day of proestrus PACAP, β-cyclodextrin (modifier of blood–brain barrier) or PACAP + β-cyclodextrin was applied intranasally between 12:30 and 13:00. Blood samples were taken at 16:00, 18:00, and 20:00 for measuring plasma hormone levels. In the next morning, the expelled ova were counted. β-Cyclodextrin was also administered to male and diestrous female rats between 12:30 and 13:00 and blood was taken at 18:00.

Results

PACAP prevented LH and PRL surges and ovulation in about half of the rats, β-cyclodextrin alone more effectively prevented ovulation. When PACAP and β-cyclodextrin were administered together, more rats ovulated like when PACAP given alone. β-Cyclodextrin did not influence LH and PRL levels in diestrous females; however, in males, it significantly enhanced PRL level.

Discussion

Not only the intracerebroventricular, but the intranasal application of PACAP prevented ovulation. β-Cyclodextrin alone is more effective than PACAP and enhances PRL levels in male rats. PACAP and β-cyclodextrin given together weaken each other’s effect. β-Cyclodextrin, as excipient of various drugs, has to be used carefully in human medications.

Open access